CME-CPD Information

CME-CPD Information

Accreditation Statement and Credit Designation

Royal College of Physicians and Surgeons of Canada – Section 1

An application has been made for CME accreditation for this event by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada.

Further information will be provided in due course.

The American Medical Association – AMA PRA Category 1

Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits™. Information on the process to convert Royal College MOC credit to AMA credit can be found at: www.ama-assn.org

European Union for Medical Specialists (UEMS/EACCME)

Live educational activities, occurring in Canada, recognized by the Royal College of Physicians and Surgeons of Canada as Accredited Group Learning Activities (Section 1) are deemed by the European Union of Medical Specialists (UEMS) eligible for ECMEC®.

TO RECEIVE YOUR CME/CPD CERTIFICATE

Kindly note that the INS 2024 online evaluation​ will be active on the last day of the meeting. ​You will then be able to access it and claim your CME/CPD certificate.

EDUCATIONAL OBJECTIVES

As a result of this educational activity, delegates will be able to:

  • Apply new scientific data and clinical guidelines to improve patient selection and treatment outcomes for neuromodulation.
  • Identify potential benefits, limitations, and complications of neuromodulation therapies.
  • Interpret study results based on trial design and apply lessons learned for application in the design of future trials.
  • Analyze psychological/psychiatric factors affecting outcomes in the treatment of chronic pain, movement disorders, cognitive and other disorders.
  • Describe the bioengineering challenges and solutions at the neural interface, fundamentals, and mechanisms of action of neuromodulation.
  • Discuss and analyze the anatomy and physiology of the central CNS, peripheral, and autonomic nervous systems to assist in patient selection, target selection, and likelihood of therapeutic success.
  • Discuss the uses of devices for functional electrical stimulation including rehabilitation of motor loss, loss of sensory function, and loss of cognitive function.
  • Describe emerging neuromodulation therapies, new paradigms of therapy target selection, and associated research in the medical field of neuromodulation.
  • Distinguish mechanisms of disease states, such as complex regional pain syndrome, refractory angina, and visceral pain syndromes, and explain the current position of neuromodulation in these conditions.
  • Explain the many variations available for electrical stimulation and how to select the appropriate technology.
  • Describe the increasing application of neuromodulation for chronic heart disease, as well as genitourinary and gastrointestinal disorders.
  • Explain the scientific merit and best practices for the use of intrathecal drug infusions including patient selection, drug selection, and complication management.
  • Critically appraise research methodology in neuromodulation and recognize the importance of evolving treatment guidelines and registries.
  • Apply the increasing knowledge base for neuromodulation in a wide variety of chronic illness management.
  • Explain how cancer pain management has evolved into managing the pain of cancer survivors and recognize the growing need for neuromodulation solutions.

TARGET AUDIENCE

The 16th INS World Congress is the global meeting place for researchers, clinicians, and other health professionals to share knowledge and ideas on neuromodulation. Because of the diverse, clinically focused educational offering, participants can tailor the curriculum to meet the needs of international clinicians of all levels of experience. The target audience includes international, regional, and national specialists as well as basic scientists in the field of neuromodulation.

Disclosure and Resolution of Personal Conflicts of Interest

Following CME/CPD accreditation criteria and standards for commercial support to ensure balance, independence, objectivity, and scientific rigor, those in control of the educational content must disclose potential or actual conflicts of interest. Disclosure information is evaluated and conflicts of interest are resolved. Disclosure is made to participants before the activity. Participants will be asked on the evaluation to assess the objectivity and independence of the event.

Disclosure information will be available here at least one week prior to the event.

Industry Support Disclosure

This event is supported, in part, by funding from industry. All support is managed in strict accordance with CME/CPD accreditation criteria and standards for commercial support. Appropriate acknowledgement of all supporting organizations is made in the program guide, on the event website, and with signage during the event.

  • View a list of all industry supporters here.

Commitment to the Highest Standards in CME/CPD

Kenes is committed to being a valuable and knowledgeable partner in the design and delivery of educationally strong, independent, transparent, and effective CME/CPD programs. Kenes is a proud member of the Good CME Practice Group (gCMEp), a member organization contributing to improving health outcomes by:

 

Championing best practices in CME/CPD

Maintaining and improving standards

Mentoring and educating

Working in collaboration with critical stakeholders

 

Membership in the Good CME Practice Group illustrates Kenes commitment to high standards and knowledgeable partnership with its clients in the design and delivery of medical events.